QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)

Axon Enterprise (AXON) Stock Price, News & Analysis

$269.00
+3.53 (+1.33%)
(As of 02/8/2024 ET)
Today's Range
$264.61
$269.50
50-Day Range
$231.51
$269.00
52-Week Range
$175.37
$270.95
Volume
306,090 shs
Average Volume
372,314 shs
Market Capitalization
$20.16 billion
P/E Ratio
137.95
Dividend Yield
N/A
Price Target
$255.36

Axon Enterprise MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.90 Rating Score
Upside/​Downside
5.1% Downside
$255.36 Price Target
Short Interest
Healthy
2.79% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.80mentions of Axon Enterprise in the last 14 days
Based on 18 Articles This Week
Insider Trading
Selling Shares
$19.96 M Sold Last Quarter
Proj. Earnings Growth
9.17%
From $2.29 to $2.50 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.42 out of 5 stars

Industrial Products Sector

154th out of 172 stocks

Ordnance & Accessories, Except Vehicles & Guided Missiles Industry

4th out of 4 stocks


AXON stock logo

About Axon Enterprise Stock (NASDAQ:AXON)

Axon Enterprise, Inc. is a leading provider of law enforcement technology solutions that enable using less-lethal weapons, body cameras, and cloud-based software. The company's mission is to protect life by providing innovative solutions that increase transparency and accountability in law enforcement. Axon's products and services include body-worn cameras, digital evidence management software, less-lethal weapons, and crime scene investigation tools.

Axon's primary target market is law enforcement agencies in the United States and abroad. The company's key customers include police departments, sheriff's offices, and federal law enforcement agencies. Axon is headquartered in Scottsdale, Arizona, with additional offices in Seattle, Washington, and London, UK. The company was founded in 1993 as TASER International Inc. and rebranded as Axon in 2017. Axon has also been recognized for its corporate social responsibility efforts, including its commitment to reducing the environmental impact of its products and operations.

Axon's management team is led by Chief Executive Officer and founder Patrick (Rick) Smith, who has been with the company since its inception. Before founding Axon, Smith worked as a software engineer at Honeywell and Intel. He has a bachelor's degree in electrical engineering from Harvard University and a master's from Stanford University.

Axon has experienced strong revenue growth over the past few years, driven by law enforcement agencies' adoption of body cameras and digital evidence management software. The company has been reporting increasing revenue each year for the past several years, and in 2022 it reached a milestone reaching meaningful profitability numbers for the first time. Axon's profit margins have also improved over the past few years, with the company reporting a gross margin averaging around 60%. Axon has a relatively low debt and more than enough assets to cover the company's debts. 

Axon's valuation metrics are relatively high compared to its industry peers, reflecting its strong growth prospects and leadership position in the law enforcement technology market. Axon's price-to-earnings ratio and price-to-book ratio are much higher than industry peers. Axon's stock price has experienced significant volatility over the past few years, driven by various factors, including regulatory changes, news events, and earnings reports. 

Axon Enterprise operates in the law enforcement technology industry, providing products and services to improve public safety. The company primarily focuses on producing and selling conducted electrical weapons (CEWs), body-worn cameras, and software solutions designed to streamline the law enforcement process.

The market for law enforcement technology is highly competitive, with major players such as Motorola Solutions, Inc. and Digital Ally Inc. competing for market share. The industry is also highly regulated, with stringent quality control and safety standards in place. Any missteps or quality issues could damage the company's reputation and lead to regulatory action.

One of Axon's key advantages in the market is its strong brand recognition and reputation for quality. The company's body-worn cameras are considered the best in the industry, and its software solutions are highly regarded. In addition, the company has built a loyal customer base over the years, with a significant percentage of its revenue coming from repeat business.

The law enforcement technology industry is facing significant headwinds. The ongoing debate around police reform and the use of force by law enforcement officers has led to increased scrutiny of companies like Axon, and there is a risk that sales could decline as a result. In addition, the industry is facing pressure from lower-cost competitors, and there is a risk that Axon's pricing strategy could become less effective in the face of increasing competition.

AXON Stock Price History

AXON Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Axon Makes 2 Announcements, TAM Expands $20B
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
Axon: Bringing AI To Law Enforcement Through Innovation
Taser Stock Axon Enterprise Jolts To A High
Taser Stock Axon Enterprise Jolts To A High
Axon Enterprise Inc.
AXON Jan 2025 230.000 call
AXON Jan 2026 170.000 call
See More Headlines
Receive AXON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axon Enterprise and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
2/08/2024
Next Earnings (Estimated)
2/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Ordnance & accessories, except vehicles & guided missiles
Sub-Industry
Systems Software
Current Symbol
NASDAQ:AXON
Employees
3,734
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$255.36
High Stock Price Target
$309.00
Low Stock Price Target
$230.00
Potential Upside/Downside
-5.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

Net Income
$147.14 million
Pretax Margin
9.13%

Debt

Sales & Book Value

Annual Sales
$1.19 billion
Cash Flow
$1.43 per share
Book Value
$17.83 per share

Miscellaneous

Free Float
70,363,000
Market Cap
$20.16 billion
Optionable
Optionable
Beta
0.90
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Should I Buy Axon Enterprise Stock? AXON Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Axon Enterprise was last updated on Tuesday, February 6, 2024 at 8:00 PM.

Pros

Here are some ways that investors could benefit from investing in Axon Enterprise, Inc.:

  • Axon Enterprise, Inc. reported better-than-expected quarterly earnings, with an EPS of $0.71, beating the consensus estimate of $0.40 by $0.31. This indicates strong financial performance and potential for future growth.
  • The company had a net margin of 9.96% and a return on equity of 12.63%, indicating efficient use of resources and profitability.
  • Axon Enterprise had revenue of $413.60 million for the quarter, surpassing analysts' expectations of $393.77 million. This demonstrates strong sales performance.
  • Several research firms have given Axon Enterprise a positive rating, with analysts increasing their price targets. This suggests confidence in the company's future prospects.
  • The average rating for Axon Enterprise is "Moderate Buy" with an average price target of $250.82, indicating potential upside for investors.

Cons

Investors should be bearish about investing in Axon Enterprise, Inc. for these reasons:

  • There is a risk associated with investing in any company, including Axon Enterprise. Investors should carefully consider their risk tolerance and conduct thorough research before making investment decisions.
  • The stock price of Axon Enterprise is subject to market fluctuations and can be influenced by various factors, including economic conditions, industry trends, and company-specific news. Investors should be aware of the potential volatility in the stock price.
  • While Axon Enterprise has shown strong financial performance in recent quarters, past performance is not indicative of future results. Investors should consider the company's long-term growth prospects and competitive landscape.
  • Investing in biotechnology companies, like Axon Enterprise, carries inherent risks related to regulatory approvals, clinical trials, and market competition. Investors should be aware of the specific risks associated with the biotechnology industry.
  • It is important for investors to diversify their portfolios and not rely solely on one investment. Axon Enterprise should be considered as part of a well-balanced investment strategy.














AXON Stock Analysis - Frequently Asked Questions

Should I buy or sell Axon Enterprise stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AXON shares.
View AXON analyst ratings
or view top-rated stocks.

What is Axon Enterprise's stock price target for 2024?

10 brokerages have issued twelve-month price objectives for Axon Enterprise's shares. Their AXON share price targets range from $230.00 to $309.00. On average, they expect the company's stock price to reach $255.36 in the next year. This suggests that the stock has a possible downside of 5.1%.
View analysts price targets for AXON
or view top-rated stocks among Wall Street analysts.

How have AXON shares performed in 2024?

Axon Enterprise's stock was trading at $258.33 at the beginning of the year. Since then, AXON shares have increased by 4.1% and is now trading at $269.00.
View the best growth stocks for 2024 here
.

When is Axon Enterprise's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our AXON earnings forecast
.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) posted its earnings results on Monday, November, 15th. The biotechnology company reported $1.17 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.91. The biotechnology company earned $231.99 million during the quarter, compared to analyst estimates of $201.11 million. Axon Enterprise had a trailing twelve-month return on equity of 12.63% and a net margin of 9.96%. The business's revenue for the quarter was up 39.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.01) EPS.

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an initial public offering (IPO) on Thursday, June 11th 2015. The company issued 17,900,000 shares at a price of $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets served as the underwriters for the IPO and JMP Securities and Baird were co-managers.

Who are Axon Enterprise's major shareholders?

Axon Enterprise's stock is owned by many different institutional and retail investors. Top institutional investors include Charles Schwab Investment Management Inc. (0.78%), Conestoga Capital Advisors LLC (0.71%), Zevenbergen Capital Investments LLC (0.69%), abrdn plc (0.52%), Allspring Global Investments Holdings LLC (0.45%) and Baillie Gifford & Co. (0.44%). Insiders that own company stock include Adriane M Brown, Brittany Bagley, Caitlin Elizabeth Kalinowski, Hadi Partovi, Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Mark W Kroll, Matthew R Mcbrady, Matthew R Mcbrady, Michael Garnreiter and Patrick W Smith.
View institutional ownership trends
.

How do I buy shares of Axon Enterprise?

Shares of AXON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AXON) was last updated on 2/8/2024 by MarketBeat.com Staff

My Account -